Success Stories: From Research Program Manager to EB1B Approval: A Recognition of Dermatological Excellence
Client’s Testimonial:
“The Chen immigration team is excellent! I always heard that EB1 processing takes so much work and patience, but they have made the process so efficient with their constant guidance. They drafted my recommendation and petition letters quicker than anticipated timelines. Worked with me to get the application submitted in a timely manner. I am extremely thankful to this team for guiding me and supporting me throughout the application process!”
On August 14th, 2025, we received another EB1B (Outstanding Professor/Researcher) approval for a Research Program Manager in the Field of Dermatology (Approval Notice).
General Field: Dermatology
Position at the Time of Case Filing: Research Program Manager
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: August 14th, 2025
Processing Time: 16 months, 20 days
Case Summary:
We are excited to share the story of an accomplished research program manager from India whose impactful work in dermatology earned a successful EB1B (Outstanding Professors and Researchers) approval through our firm. With a strong background in research coordination and strategic management of dermatological studies, this client has proven her vital role in advancing both academic and clinical knowledge in the field.
Scientific Leadership in Dermatology
The client’s work has centered on bridging clinical applications and investigative dermatological science. By managing large-scale research initiatives and contributing to innovations in skin biology and disease, the client’s contributions support the development of improved therapeutic strategies for chronic skin conditions and inflammatory disorders. The client’s scholarly output includes numerous peer-reviewed journal articles that have been cited extensively by independent researchers, reflecting the sustained relevance of her work.
Beyond publication impact, the client has served as a reviewer for peer-reviewed journals, demonstrating both subject matter expertise and thought leadership. Her ability to assess and guide the research of others is a marker of her influence in the broader dermatology research community. Her work includes:
- 17 peer-reviewed journal articles and abstracts
- Cited 103 times according to Google Scholar
Endorsements from the Field
We bolstered the petition with detailed expert letters, including one that stated:
“The [client] has consistently demonstrated scientific acumen, leadership in interdisciplinary collaboration, and the ability to drive research with clear translational significance. Her work continues to inform our understanding of inflammatory skin conditions in diverse patient populations.”
These testimonials reinforced our assertion that the client’s work is both original and of major significance to the field.
Proving Eligibility under EB1B Criteria
Our legal team structured the EB1B petition to clearly present how the client met multiple regulatory requirements—demonstrating international recognition, original scientific contributions, a strong publication and citation record, and essential roles in major research projects. The petition also detailed the client’s involvement with funded initiatives, affirming the high level of trust placed in her expertise by institutions and collaborators.
NIW Approval and Outlook
The case was filed on March 25, 2024, and was approved on August 14, 2025, reflecting a strong and well-supported petition. We are proud to have guided this dedicated dermatology researcher through the EB1B process, helping secure her future contributions to skin health and clinical innovation in the U.S.